7 Jul 2010 16:55
7 July 2010
Phorm, Inc. ("Phorm" or the "Company")
Director's Dealings
Phorm (AIM: PHRM and PHRX), the personalisation technology company, today announces that, pursuant to the previously announced placing undertaken by Mirabaud Securities LLP, on behalf of the Company, Stephen Partridge-Hicks, a non-executive Director of the Company, subscribed to 11,700 shares of $0.001 at the Placing Price. Following this subscription, Mr Partridge-Hicks holds 23,700 common shares representing 0.13 per cent. of the issued share capital of the Company.
Enquiries:
Phorm, Inc.
Sarah Simon +44 20 7297 2433 (analysts and investors)
Alex Laity +44 20 7297 2710 (press)
Citigate Dewe Rogerson +44 20 7638 9571
Simon Rigby
Justin Griffiths
Canaccord Genuity Limited +44 20 7050 6500
(Nominated Adviser)
Mark Williams
Andrew Chubb